DK569886D0 - Fremstilling af human somatomedin c - Google Patents

Fremstilling af human somatomedin c

Info

Publication number
DK569886D0
DK569886D0 DK569886A DK569886A DK569886D0 DK 569886 D0 DK569886 D0 DK 569886D0 DK 569886 A DK569886 A DK 569886A DK 569886 A DK569886 A DK 569886A DK 569886 D0 DK569886 D0 DK 569886D0
Authority
DK
Denmark
Prior art keywords
dna sequences
human
preparation
optimal
production
Prior art date
Application number
DK569886A
Other languages
English (en)
Other versions
DK569886A (da
DK175223B1 (da
Inventor
Gary N Buell
Nageswararao Movva
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of DK569886A publication Critical patent/DK569886A/da
Publication of DK569886D0 publication Critical patent/DK569886D0/da
Application granted granted Critical
Publication of DK175223B1 publication Critical patent/DK175223B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK198605698A 1985-03-26 1986-11-26 Fremgangsmåde til forbedring af produktionen af et önsket polypeptid, DNA-sekvens og rekombinant DNA-molekyle kodende for polypeptidet, værtscelle transformeret med det rekombinante DNA-molekyle og fremgangsmåde til fremstilling af et polypeptid DK175223B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8507833 1985-03-26
GB858507833A GB8507833D0 (en) 1985-03-26 1985-03-26 Production of human somatomedin c
US8600579 1986-03-25
PCT/US1986/000579 WO1986005810A1 (en) 1985-03-26 1986-03-25 Production of human somatomedin c

Publications (3)

Publication Number Publication Date
DK569886A DK569886A (da) 1986-11-26
DK569886D0 true DK569886D0 (da) 1986-11-26
DK175223B1 DK175223B1 (da) 2004-07-12

Family

ID=10576658

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198605698A DK175223B1 (da) 1985-03-26 1986-11-26 Fremgangsmåde til forbedring af produktionen af et önsket polypeptid, DNA-sekvens og rekombinant DNA-molekyle kodende for polypeptidet, værtscelle transformeret med det rekombinante DNA-molekyle og fremgangsmåde til fremstilling af et polypeptid

Country Status (14)

Country Link
EP (1) EP0215110B1 (da)
JP (4) JPH0691832B2 (da)
CN (1) CN1034588C (da)
AT (1) ATE87977T1 (da)
AU (1) AU594950B2 (da)
CA (1) CA1339305C (da)
DE (1) DE3688225T2 (da)
DK (1) DK175223B1 (da)
ES (1) ES8705921A1 (da)
GB (1) GB8507833D0 (da)
IL (1) IL78278A0 (da)
NO (1) NO302709B1 (da)
WO (1) WO1986005810A1 (da)
ZA (1) ZA862240B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221789A (en) * 1986-09-12 1991-05-28 Genentech Inc Recombinant prorelaxin, its preparation and pharmaceutical compositions comprising it
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
US4876242A (en) * 1987-09-21 1989-10-24 Merck & Co., Inc. Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
AUPP807899A0 (en) * 1999-01-08 1999-02-04 University Of Queensland, The Codon utilization
JP6018719B1 (ja) * 2016-03-15 2016-11-02 Ｂｘ新生精機株式会社 シャッター開閉機の巻上装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0561137B1 (en) * 1983-04-25 2002-07-03 Chiron Corporation Hybrid DNA Synthesis of Mature Insulin-like Growth Factors
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
EP0151760A1 (en) * 1984-01-06 1985-08-21 Takeda Chemical Industries, Ltd. Novel DNA and use thereof
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields

Also Published As

Publication number Publication date
IL78278A0 (en) 1986-07-31
ES8705921A1 (es) 1987-05-16
JPH07145200A (ja) 1995-06-06
EP0215110B1 (en) 1993-04-07
NO864724L (no) 1987-01-23
ES553374A0 (es) 1987-05-16
JPS62502305A (ja) 1987-09-10
CA1339305C (en) 1997-08-19
DE3688225D1 (de) 1993-05-13
EP0215110A1 (en) 1987-03-25
ZA862240B (en) 1986-11-26
CN1034588C (zh) 1997-04-16
JPH0691832B2 (ja) 1994-11-16
AU5665786A (en) 1986-10-23
CN86102889A (zh) 1986-11-26
JPH07102152B2 (ja) 1995-11-08
DK569886A (da) 1986-11-26
JPH07143896A (ja) 1995-06-06
NO302709B1 (no) 1998-04-14
DE3688225T2 (de) 1993-07-22
DK175223B1 (da) 2004-07-12
WO1986005810A1 (en) 1986-10-09
EP0215110A4 (en) 1987-07-09
GB8507833D0 (en) 1985-05-01
AU594950B2 (en) 1990-03-22
ATE87977T1 (de) 1993-04-15
JP2568383B2 (ja) 1997-01-08
JPH07143885A (ja) 1995-06-06
JP2602628B2 (ja) 1997-04-23

Similar Documents

Publication Publication Date Title
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DK666888A (da) Human vaevsfaktor-relaterende dna-segmenter, polypeptider og antistoffer
DK110885D0 (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
CH0229046H1 (de) Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
DK375283A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af kvaegvaeksthormonlignende polypeptider
ES2059354T3 (es) Un metodo para producir un polipeptido.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ATE388165T1 (de) Menschliches cnp-gen und vorläuferprotein
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
MX164375B (es) Procedimiento biotecnologico para preparar moleculas adn recombinantes y polipeptidos de tipo de hormona de crecimiento en cerdos
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
DK568587D0 (da) Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer
DK178386A (da) Rekombinant dna-udtrykkelsesvektor og dna-forbindelser, der udtrykker isopenicillin n synthetase
DK569886A (da) Fremstilling af human somatomedin c
KR900700604A (ko) 오이 모자이크 바이러스 코트 단백질 유전자
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
DE3786870D1 (de) Methode zur herstellung von proteinen.
DK145988D0 (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi
ATE83800T1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
ATE92528T1 (de) Methode zur herstellung von proteinen.

Legal Events

Date Code Title Description
PUP Patent expired